Anouk E. Muller

Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society

Burn wound healing and treatment: review and advancements

Variation in Mutant Prevention Concentrations

What’s new in therapeutic drug monitoring of antimicrobials?

Antibiotic resistance: a rundown of a global crisis

Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions

Ceftazidime-Avibactam: A Review in the Treatment of Serious Gram-Negative Bacterial Infections

The concept of iron bioavailability and its assessment

Applicability of an in vitro digestion model in assessing the bioaccessibility of mycotoxins from food

Ferrous Sulfate Supplementation Causes Significant Gastrointestinal Side-Effects in Adults: A Systematic Review and Meta-Analysis

A Phase 3 Randomized Double-Blind Comparison of Ceftobiprole Medocaril Versus Ceftazidime Plus Linezolid for the Treatment of Hospital-Acquired Pneumonia

Diagnosis and treatment of urinary tract infections across age groups

AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both

Revolutionizing healthcare: the role of artificial intelligence in clinical practice

Activity of ceftobiprole against methicillin-resistant Staphylococcus aureus strains with reduced susceptibility to daptomycin, linezolid or vancomycin, and strains with defined SCCmec types

Urinary tract infections: epidemiology, mechanisms of infection and treatment options

Sexually Transmitted Infections Treatment Guidelines, 2021

Clinical iron deficiency disturbs normal human responses to hypoxia

Antibiotic Resistance Profiles, Molecular Mechanisms and Innovative Treatment Strategies of Acinetobacter baumannii

Oral supplementation with ferrous sulfate but not with non-ionic iron polymaltose complex increases the susceptibility of plasma lipoproteins to oxidation

Pharmacokinetic considerations regarding the treatment of bacterial sexually transmitted infections with azithromycin: a review

Bacterial Antibiotic Resistance: The Most Critical Pathogens

The Pharmacokinetics and Pharmacodynamics of Iron Preparations

Immune Activation and Suppression by Group B Streptococcus in a Murine Model of Urinary Tract Infection

Natural product and natural product derived drugs in clinical trials

Ceftobiprole: drug evaluation and place in therapy

The antibiotic pipeline: reviving research and development and speeding drugs to market

How to optimize antibiotic pharmacokinetic/pharmacodynamics for Gram-negative infections in critically ill patients

Bacterial and Fungal Coinfection in Individuals With Coronavirus: A Rapid Review To Support COVID-19 Antimicrobial Prescribing

Enterobacter spp.: Update on Taxonomy, Clinical Aspects, and Emerging Antimicrobial Resistance

Antimicrobial Resistance in ESKAPE Pathogens

Morbidity related to maternal group B streptococcal infections

Model-informed precision dosing of beta-lactam antibiotics and ciprofloxacin in critically ill patients: a multicentre randomised clinical trial

Optimal exposures of ceftazidime predict the probability of microbiological and clinical outcome in the treatment of nosocomial pneumonia

Use of old antibiotics now and in the future from a pharmacokinetic/pharmacodynamic perspective

Dynamics of colistin and tobramycin resistance among Enterobacter cloacae during prolonged use of selective decontamination of the digestive tract

Nitrofurantoin revisited: a systematic review and meta-analysis of controlled trials

Pharmacokinetics and Target Attainment of Ceftobiprole in Asian and Non‐Asian Subjects

Monte Carlo Simulations Based on Phase 1 Studies Predict Target Attainment of Ceftobiprole in Nosocomial Pneumonia Patients: a Validation Study

MIC-based dose adjustment: facts and fables

Exposure to Ceftobiprole Is Associated with Microbiological Eradication and Clinical Cure in Patients with Nosocomial Pneumonia

Pharmacokinetics of iron salts and ferric hydroxide-carbohydrate complexes.